Max Cotler

Company: GelMEDIX

Job title: Chief Operating Officer

Seminars:

Roundtable Discussion: What is the Ideal Combination of Formulation & Device? 11:00 am

Discussing the Desired Characteristics for a Benchmark: • Assessing different formulations being utilized for ophthalmic delivery and understanding their shortfalls • Discussing the triumphs and tribulations of novel ocular delivery devices, from the hot new suprachoroidal delivery mechanism to the classic intravitreal and subretinal injections and the much-desired topical delivery method • Examining patient concerns…Read more

day: Conference Day Two

Designing & Developing Precise & Specialized Formulations for Device and Drug Products for Retinal Cell Replacement Therapy 10:30 am

Advantages and disadvantages of using liquid vs. hydrogel formulations for subretinal injections Using gel and suspension formulations for subretinal delivery for cell replacement therapies Leveraging lessons from recent studies surrounding subretinal injection of suspension formulationRead more

day: Conference Day Two